Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis

Cancer radioimmunotherapy

(2011) Robert M Sharkey et al.   Immunotherapy

Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging

(2011) J. Hoppin et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin

(2011) S. V. Bhagwat et al.   MOLECULAR CANCER THERAPEUTICS

Mitochondrial F1Fo-ATP synthase translocates to cell surface in hepatocytes and has high activity in tumor-like acidic and hypoxic environment

(2010) Zhan Ma et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma

(2010) Pierre-Yves Salaun et al.   CANCER

Effect of a novel inhibitory mAb antibody against β-subunit of F1F0 ATPase on HCC

(2010) Jingbo Wang et al.   CANCER BIOLOGY & THERAPY

Immuno-PET Quantitation of de2-7 Epidermal Growth Factor Receptor Expression in Glioma Using 124I-IMP-R4-Labeled Antibody ch806

(2010) F. T. Lee et al.   JOURNAL OF NUCLEAR MEDICINE

Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease

(2009) Mohammad Tabrizi et al.   AAPS Journal

Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells1

(2008) Xia ZHANG et al.   ACTA PHARMACOLOGICA SINICA

Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody

(2008) Thamar H. Stollman et al.   INTERNATIONAL JOURNAL OF CANCER

A Versatile Bifunctional Chelate for Radiolabeling Humanized Anti-CEA Antibody with In-111 and Cu-64 at Either Thiol or Amino Groups: PET Imaging Of CEA-Positive Tumors with Whole Antibodies

(2007) Lin Li et al.   BIOCONJUGATE CHEMISTRY